by Peter Ciszewski | Jul 11, 2018
Editor’s Note: This interview was conducted at #Bio2018. Please pardon the background noise. Jim Schulz, Co-founder and Chief Financial Officer of Scioto Biosciences, discusses his company’s focus on developing therapies devoted to having a impact on the...
by Peter Ciszewski | Jul 10, 2018
Gail Cawkwell, MD, PhD, Senior Vice President, Medical Affairs at Intercept, provides an overview of primary biliary cholangitis (PBC), a rare liver disease that is caused by an autoimmune reaction. Primary biliary cholangitis affects the bile ducts within the...
by Peter Ciszewski | Jul 8, 2018
Editor’s Note: This interview was conducted at #Bio2018. Please pardon the background noise. Brian Schwartz, Chief Medical Officer of ArQule, discusses his company and it’s clinical-stage pipeline consistlng of five drug candidates, all of which are...
by Peter Ciszewski | Jul 7, 2018
Editor’s Note: This interview was conducted at #Bio2018. Please pardon the background noise. Richard West, Founder and CEO of Baebies, a newborn testing diagnostic company. Baebies was founded in 2014, following the successful development of digital...
by Peter Ciszewski | Jul 5, 2018
Editor’s Note: This interview was conducted at #Bio2018. Please pardon the background noise. Dr. Shenda Baker is Chief Executive Officer of Synspira, a clinical stage biotech company developing a new class of glycopolymer-based therapeutics that have the...
